20 December 2023 in Protein Science
10 February 2025 in IEEE Journal of Biomedical and Health Informatics
T cell receptors (TCRs) play a crucial role in numerous immunotherapies targeting tumor cells. However, their acquisition and optimization present significant challenges, involving laborious and time-consuming wet lab experimental resource. Deep generative models have demonstrated remarkable capabilities in functional protein sequence generation, offering a promising solution for enhancing the acquisition of specific TCR sequences. Here, we propose GRATCR, a framework incorporates two pre-trained modules through a novel “grafting” strategy, to de-novo generate TCR sequences targeting specific epitopes. Experimental results demonstrate that TCRs generated by GRATCR exhibit higher specificity toward desired epitopes and are more biologically functional compared with the state-of-the-art model, by using significantly fewer training data. Additionally, the generated sequences display novelty compared to natural sequences, and the interpretability evaluation further confirmed that the model is capable of capturing important binding patterns.
24 October 2026 in Genomics, Proteomics & Bioinformatics
Messenger RNA (mRNA) vaccines offer promising therapeutic potential for combating various diseases, yet their inherent chemical instability hampers long-term efficacy. Although several methods have been developed to predict mRNA degradation, they often suffer from limited accuracy and lack the capability for rational codon optimization. Here, we propose RNASTOP, a novel framework that integrates deep learning with heuristic search to simultaneously predict and optimize mRNA chemical stability. RNASTOP achieves a 13% improvement in accuracy over the top-performing model on the Stanford OpenVaccine competition dataset and demonstrates robust generalization in predicting full-length mRNA degradation. When applied to mRNA codon optimization, RNASTOP reduces the minimum free energy of the varicella-zoster virus vaccine sequence by 75.73% while maintaining high translation efficiency. Overall, RNASTOP serves as a powerful tool for predicting and optimizing mRNA chemical stability, accelerating the development of mRNA therapeutics. The source code of RNASTOP is available at https://github.com/xlab-BioAI/RNASTOP.